- Home
- OGS vs ICUI Comparison
OGS vs ICUI Comparison
Compare OGS & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGS
- ICUI
- Stock Information
- Founded
- OGS 1906
- ICUI 1984
- Country
- OGS United States
- ICUI United States
- Employees
- OGS N/A
- ICUI N/A
- Industry
- OGS Oil/Gas Transmission
- ICUI Medical/Dental Instruments
- Sector
- OGS Utilities
- ICUI Health Care
- Exchange
- OGS Nasdaq
- ICUI Nasdaq
- Market Cap
- OGS 3.8B
- ICUI 3.8B
- IPO Year
- OGS N/A
- ICUI 1992
- Fundamental
- Price
- OGS $69.88
- ICUI $161.08
- Analyst Decision
- OGS Hold
- ICUI Buy
- Analyst Count
- OGS 6
- ICUI 4
- Target Price
- OGS $70.92
- ICUI $199.67
- AVG Volume (30 Days)
- OGS 392.4K
- ICUI 200.3K
- Earning Date
- OGS 02-19-2025
- ICUI 02-25-2025
- Dividend Yield
- OGS 3.80%
- ICUI N/A
- EPS Growth
- OGS N/A
- ICUI N/A
- EPS
- OGS 3.82
- ICUI N/A
- Revenue
- OGS $2,058,772,000.00
- ICUI $2,340,097,000.00
- Revenue This Year
- OGS $3.25
- ICUI $4.38
- Revenue Next Year
- OGS $7.51
- ICUI $0.34
- P/E Ratio
- OGS $18.17
- ICUI N/A
- Revenue Growth
- OGS N/A
- ICUI 4.04
- 52 Week Low
- OGS $57.74
- ICUI $86.80
- 52 Week High
- OGS $78.89
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- OGS 48.66
- ICUI 51.79
- Support Level
- OGS $66.38
- ICUI $151.92
- Resistance Level
- OGS $69.98
- ICUI $167.49
- Average True Range (ATR)
- OGS 1.27
- ICUI 4.52
- MACD
- OGS 0.23
- ICUI 0.73
- Stochastic Oscillator
- OGS 91.97
- ICUI 61.01
About OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.